Detalhe da pesquisa
1.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
J Neurol Neurosurg Psychiatry
; 91(9): 914-920, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661083
2.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci
; 41(10): 2905-2913, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335779
3.
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study.
Mult Scler
; 25(3): 399-407, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29363396
4.
Prognostic indicators in pediatric clinically isolated syndrome.
Ann Neurol
; 81(5): 729-739, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28439957
5.
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study).
PLoS One
; 12(8): e0180651, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28763462
6.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Mult Scler Int
; 2015: 763418, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26266049
7.
Cost-analysis of relapsing-remitting multiple sclerosis in Italy after the introduction of new disease-modifying agents.
Clin Drug Investig
; 24(7): 409-20, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-17516727